BioWorld MedTech

March 26, 2013

View Archived Issues

Deals roundup: Argon to acquire Angiotech interventional unit for $362M

In a move to perhaps eliminate a significant portion of its debt, Angiotech Pharmaceuticals (Vancouver, British Columbia) reported the sale of its interventional products business to Argon Medical Devices (Plano, Texas) for $362.5 million. Read More

Third Rock raises $516M in oversubscribed Fund III

Read More

Financings roundup: Bausch + Lomb files IPO registration statement

Read More

Washington roundup: FDA warning to Stryker offers no insight into Neptune recall

Read More

International report: Stereotaxis receives regulatory approval of Niobe tech in Japan

Read More

Agreements/contracts: Aerocrine, Medisoft agree to licensing settlement terms

Read More

Court report: BCBSM files motion to dismiss antitrust lawsuit filed against it

Read More

Grants roundup: Stanford pediatric cancer study receives funding

Read More

Med-Tech Notes

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Cardio Extra

Read More